Shandong Pharmaceutical Glass Co Ltd (600529) — Strategic Asset Allocation Index
Shandong Pharmaceutical Glass Co Ltd (600529) has a Strategic Asset Allocation Index of 40.2% as of June 2023. Strategic assets (PP&E of CN¥2.87 Billion plus long-term investments of CN¥-) total CN¥2.87 Billion, measured against net assets of CN¥7.15 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check financial resilience of Shandong Pharmaceutical Glass Co Ltd to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Shandong Pharmaceutical Glass Co Ltd Strategic Asset Allocation Index (2000–2022)
This chart shows how Shandong Pharmaceutical Glass Co Ltd's Strategic Asset Allocation Index has evolved across 23 annual periods from 2000 to 2022. As of June 2023, the index stands at 40.2%, representing strategic assets of CN¥2.87 Billion against net assets of CN¥7.15 Billion CNY. See Shandong Pharmaceutical Glass Co Ltd free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Shandong Pharmaceutical Glass Co Ltd (2000–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Shandong Pharmaceutical Glass Co Ltd from 2000 to 2022, covering 23 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Shandong Pharmaceutical Glass Co Ltd market cap and net worth.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 40.5% | CN¥2.82 Billion | CN¥2.82 Billion | CN¥- | CN¥6.96 Billion | ▼ -14.2 pp |
| 2021 | 54.7% | CN¥2.56 Billion | CN¥2.56 Billion | CN¥- | CN¥4.67 Billion | ▲ +5.1 pp |
| 2020 | 49.6% | CN¥2.11 Billion | CN¥2.11 Billion | CN¥- | CN¥4.26 Billion | ▼ -0.3 pp |
| 2019 | 49.9% | CN¥1.93 Billion | CN¥1.93 Billion | CN¥- | CN¥3.87 Billion | ▲ +12.5 pp |
| 2018 | 37.4% | CN¥1.32 Billion | CN¥1.32 Billion | CN¥50.00K | CN¥3.53 Billion | ▼ -1.9 pp |
| 2017 | 39.3% | CN¥1.28 Billion | CN¥1.28 Billion | CN¥50.00K | CN¥3.25 Billion | ▼ -1.4 pp |
| 2016 | 40.7% | CN¥1.24 Billion | CN¥1.24 Billion | CN¥50.00K | CN¥3.04 Billion | ▼ -12.0 pp |
| 2015 | 52.7% | CN¥1.18 Billion | CN¥1.18 Billion | CN¥50.00K | CN¥2.24 Billion | ▼ -1.0 pp |
| 2014 | 53.8% | CN¥1.14 Billion | CN¥1.14 Billion | CN¥- | CN¥2.13 Billion | ▼ -6.7 pp |
| 2013 | 60.5% | CN¥1.23 Billion | CN¥1.23 Billion | CN¥- | CN¥2.03 Billion | ▼ -2.7 pp |
| 2012 | 63.2% | CN¥1.23 Billion | CN¥1.23 Billion | CN¥- | CN¥1.94 Billion | ▼ -1.2 pp |
| 2011 | 64.5% | CN¥1.19 Billion | CN¥1.19 Billion | CN¥- | CN¥1.85 Billion | ▲ +6.7 pp |
| 2010 | 57.8% | CN¥1.01 Billion | CN¥1.01 Billion | CN¥- | CN¥1.75 Billion | ▲ +1.2 pp |
| 2009 | 56.6% | CN¥901.78 Million | CN¥901.78 Million | CN¥- | CN¥1.59 Billion | ▼ -3.5 pp |
| 2008 | 60.1% | CN¥873.34 Million | CN¥873.34 Million | CN¥- | CN¥1.45 Billion | ▼ -0.2 pp |
| 2007 | 60.3% | CN¥788.21 Million | CN¥788.21 Million | CN¥- | CN¥1.31 Billion | ▼ -17.3 pp |
| 2006 | 77.6% | CN¥717.52 Million | CN¥717.52 Million | CN¥- | CN¥924.74 Million | ▼ -2.7 pp |
| 2005 | 80.3% | CN¥691.43 Million | CN¥691.43 Million | CN¥- | CN¥861.57 Million | ▼ -1.6 pp |
| 2004 | 81.9% | CN¥652.84 Million | CN¥652.84 Million | CN¥- | CN¥797.19 Million | ▲ +7.3 pp |
| 2003 | 74.6% | CN¥540.69 Million | CN¥540.69 Million | CN¥- | CN¥725.23 Million | ▲ +29.2 pp |
| 2002 | 45.3% | CN¥294.91 Million | CN¥294.91 Million | CN¥- | CN¥650.32 Million | ▼ -38.8 pp |
| 2001 | 84.1% | CN¥188.69 Million | CN¥188.69 Million | CN¥- | CN¥224.34 Million | ▲ +8.7 pp |
| 2000 | 75.5% | CN¥142.10 Million | CN¥142.10 Million | CN¥- | CN¥188.33 Million | — |